NCT02111161 - Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions

Necrotizing Soft Tissue InfectionNecrotizing FasciitisGas GangreneFournier Gangrene

Interventions

DRUG

IVIG (Privigen)

Three doses of 25 g IVIG (250 ml)

DRUG

Saline 0.9%

Three doses of Saline 0.9% (250 ml)

Trial Locations (1)

Dept. of Intensive Care 4131, Copenhagen University Hospital, Rigshospitalet, Copenhagen